Blogs

The US Food and Drug Administration (FDA) has issued Draft Guidance on Considering Whether an FDA-Regulated Product Involves Application of Nanotechnology, establishing a framework for the regulation and oversight of this emerging science. Some nanotechnology experts have pushed for more explicit guidelines in the nanotechnology field to help spur innovation and commercialization. “With this guidance, we are not announcing a regulatory definition of nanotechnology,” said FDA Commissioner Margaret Hamburg, MD. “However, as a first step, we want to narrow the discussion to these points and work with industry to determine if this focus is an appropriate starting place.”

Read more:

• FDA working to establish nanotechnology guidelines (Molecular Imaging)
• FDA Invites Public Comment On Nanotechnology (Industry Week)
• Federal agencies to study guidelines on nanomaterials (Washington Post)
• FDA Takes 'First Step' Toward Greater Regulatory Certainty Around Nanotechnology (FDA press release)